Upcoming Fda Approvals 2025. Upcoming fda approval decisions in q1 2025. Almost half of all novel medications approved by the u.s.

Analysts from jmp securities increased dbv technologies’ stock price target to $10 after highlighting key upcoming catalysts and anticipating a busy 2025. This article aims to support pharmacists by providing periodic updates on new and anticipated novel drug approvals.